Category: Latest News

New data presented at EHA 2026 showed durable long-term outcomes for BRUKINSA in patients aged 80 and older, while additional real-world analyses reinforced its competitive position in chronic lymphocytic leukemia. Key Investor Takeaways Why ONC Stock Is In Focus BeOne unveiled one of the largest datasets to date evaluating first-line BRUKINSA treatment in patients aged…

The cybersecurity company earned the top Growth and Innovation ranking as enterprises increasingly prioritize runtime protection for cloud and AI workloads. Key Investor Takeaways Why CRWD Stock Is In Focus CrowdStrike announced that Frost & Sullivan named the company the leader in its 2026 Frost Radar™: Cloud and Application Runtime Security report for the second…

The agreement covers Amazon services and devices, including Prime Video, while resolving ongoing litigation and advancing InterDigital’s video licensing strategy. Key Investor Takeaways Why IDCC Stock Is In Focus InterDigital announced a new patent license agreement with Amazon that covers a range of Amazon products and services, including its Prime Video streaming platform. As part…

The company and its joint venture partner have begun building and testing the first phase of a planned large-scale computing infrastructure deployment in Alberta. Key Investor Takeaways Why KMRK Stock Is In Focus K-Tech Solutions and Aurora AZ Energy announced that construction has officially started on the first 5 MW phase of their Alberta-based computing…

New data presented at EACR 2026 highlighted anti-tumor activity, improved safety characteristics, and pharmacokinetic advantages for Purple Biotech’s lead immunotherapy candidate as it advances toward human testing. Key Investor Takeaways Why PPBT Stock Is In Focus Purple Biotech presented new preclinical findings for IM1240, the lead candidate from its CAPTN-3 platform, at the European Association…

The company finalized a series of equity and equity-linked offerings aimed at funding component purchases for a rapidly growing pipeline of AI server orders. Key Investor Takeaways Why SMCI Stock Is In Focus Super Micro announced the pricing of a large financing package designed to support fulfillment of approximately $39 billion in AI server orders…

Updated ELVN-001 results showed strong molecular response rates in previously treated CML patients, while the FDA aligned with the company on key elements of its planned Phase 3 study. Key Investor Takeaways Why ELVN Stock Is In Focus Enliven Therapeutics announced updated clinical results from its ongoing Phase 1 ENABLE study evaluating ELVN-001 in patients…

The company has moved its Laser Shield Anti-Drone platform into demonstrations with U.S. and international defense stakeholders, marking a key step toward potential procurement opportunities. Key Investor Takeaways Why LASE Stock Is In Focus Laser Photonics announced the completion of final assembly for its Laser Shield Anti-Drone (LSAD) prototype, a milestone that shifts the program…